Hereditary neuropathy with liability to pressure palsies with a small deletion interrupting the PMP22 gene
R A C van de Wetering1, A A W M Gabreëls-Festen, V Timmerman
1Institute of Neurology, University Medical Centre Nijmegen, Nijmegen, The Netherlands
Abstract:
Hereditary neuropathy with liability to pressure palsies is associated with a deficiency in the Peripheral Myelin Protein 22 (PMP22). Most hereditary neuropathy with liability to pressure palsies cases are caused by a deletion of a 1.5 Mb region on chromosome 17p11.2-12 encompassing the PMP22 gene. We describe a hereditary neuropathy with liability to pressure palsies family that lacks the common deletion, but carries a small deletion spanning the 3' region of the PMP22 gene, causing only a partial deletion of one copy of the gene.
Insights
Hereditary neuropathy with liability to pressure palsies (HNPP) can result from a partial deletion of the PMP22 gene. This study identifies a novel small deletion in the PMP22 gene in an HNPP family, differing from the common large deletion.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Hereditary neuropathy with liability to pressure palsies (HNPP) is a genetic disorder affecting peripheral nerves.
- It is typically caused by a large deletion on chromosome 17p11.2-12, which includes the Peripheral Myelin Protein 22 (PMP22) gene.
- PMP22 is crucial for the formation and maintenance of myelin sheaths in peripheral nerves.
Observation:
- A family with HNPP was identified who did not possess the common 1.5 Mb deletion on chromosome 17p11.2-12.
- Genetic analysis revealed a distinct, smaller deletion within this family.
- This novel deletion specifically targets the 3' region of the PMP22 gene.
Findings:
- The identified deletion results in a partial deletion of one copy of the PMP22 gene.
- This partial deletion leads to a deficiency in PMP22, consistent with the PMP22 deficiency observed in typical HNPP cases.
- This finding expands the known genetic mechanisms underlying HNPP.
Implications:
- This discovery broadens the understanding of genetic mutations causing HNPP.
- It highlights the importance of PMP22 gene dosage in peripheral nerve health.
- This may lead to improved genetic diagnostics and counseling for families affected by HNPP.
Related Concept Videos
Abnormal Proliferation
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Pleiotropy
Parkinson Disease ll: Pathophysiology
Huntington Disease l: Introduction
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

